SCRI - Tennessee Oncology - Nashville - Centennial — Nashville, Tennessee

SCRI - Tennessee Oncology - Nashville - Centennial is a clinical research site located in Nashville, Tennessee, United States 37203-1625.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

SCRI - Tennessee Oncology - Nashville - Centennial has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Glioblastoma, Multiple Myeloma, Carcinoma, Non-Small-Cell Lung.

Sponsors: Denovo Biopharma LLC, Takeda.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Tennessee Oncology - Nashville - Centennial?

SCRI - Tennessee Oncology - Nashville - Centennial has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Tennessee Oncology - Nashville - Centennial conducted?

SCRI - Tennessee Oncology - Nashville - Centennial has 3 clinical trials on record, with 1 currently active. Their work covers Glioblastoma, Multiple Myeloma, Carcinoma, Non-Small-Cell Lung.

Is SCRI - Tennessee Oncology - Nashville - Centennial accredited by Crixeo Clinical Trials?

SCRI - Tennessee Oncology - Nashville - Centennial has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Tennessee Oncology - Nashville - Centennial?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.